Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression
- PMID: 22123272
- PMCID: PMC3233981
- DOI: 10.1097/JGP.0b013e3182051a9b
Impact of Medicare Part D on antidepressant treatment, medication choice, and adherence among older adults with depression
Abstract
Objectives: Depression in older adults is often undertreated due, in part, to medication costs. We examined the impact of improved prescription drug coverage under Medicare Part D on use of antidepressants, medication choice, and adherence.
Design, setting and participants: Observational claims-based study of older adults with depression (ICD-9: 296.2, 296.3, 311, 300.4) continuously enrolled in a Medicare managed care plan between 2004 and 2007. Three groups with limited ($150 or $350 quarterly caps) or no drug coverage in 2004-2005 obtained Part D benefits in 2006. A comparison group had stable employer-sponsored coverage throughout.
Measurements: Any antidepressant prescription fill, antidepressant choice (tricyclics or monoamine oxidase inhibitors versus newer antidepressants), and adherence (80% of days covered) in the first 6 months of treatment.
Results: : Part D was associated with increased odds of any antidepressant use among those who previously lacked coverage (odds ratio [OR] 1.61, 95% confidence interval [CI] 1.41-1.85) but odds of use did not change among those with limited prior coverage. Use of older antidepressant agents did not change with Part D. All three groups whose coverage improved with Part D had significantly higher odds of 80% of days covered with an antidepressant (OR = 1.86 [95% CI: 1.44-2.39] for no coverage, 1.74 [95% CI: 1.25%3.42] for $150 cap; and 1.19 [95% CI: 1.06-1.34] for the $350 cap groups).
Conclusions: Medicare Part D was associated with improvements in antidepressant use and adherence in depressed older adults who previously had no or limited drug coverage but not with changes in use of older agents. use and adherence in depressed older adults who previously had no or limited drug coverage but not with changes in use of older agents.
Figures
Similar articles
-
Differences in medication adherence and healthcare resource utilization patterns: older versus newer antidepressant agents in patients with depression and/or anxiety disorders.CNS Drugs. 2008;22(11):963-73. doi: 10.2165/00023210-200822110-00005. CNS Drugs. 2008. PMID: 18840035
-
The effect of the US Medicare Part D coverage gaps on medication use among patients with depression and heart failure.J Ment Health Policy Econ. 2012 Sep;15(3):105-18. J Ment Health Policy Econ. 2012. PMID: 23001279 Free PMC article.
-
Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.J Manag Care Pharm. 2006 Jan-Feb;12(1):43-54. doi: 10.18553/jmcp.2006.12.1.43. J Manag Care Pharm. 2006. PMID: 16420107 Free PMC article.
-
Medicare Part D and quality of prescription medication use in older adults.Drugs Aging. 2011 Oct 1;28(10):797-807. doi: 10.2165/11595250-000000000-00000. Drugs Aging. 2011. PMID: 21970307 Free PMC article. Review.
-
Psychosocial interventions to improve adherence in depressed and anxious older adults prescribed antidepressant pharmacotherapy: a scoping review.Ther Adv Psychopharmacol. 2023 Nov 20;13:20451253231212322. doi: 10.1177/20451253231212322. eCollection 2023. Ther Adv Psychopharmacol. 2023. PMID: 38022838 Free PMC article. Review.
Cited by
-
The Value of Medicare Coverage on Depressive Symptoms Among Older Immigrants.Gerontologist. 2024 Feb 1;64(2):gnad070. doi: 10.1093/geront/gnad070. Gerontologist. 2024. PMID: 37330627 Free PMC article.
-
The Impact of Payment Scheme Changes on Medication Adherence and Persistence of Patients Diagnosed with Depression in Korea.Int J Environ Res Public Health. 2022 Sep 5;19(17):11100. doi: 10.3390/ijerph191711100. Int J Environ Res Public Health. 2022. PMID: 36078819 Free PMC article.
-
Pharmaceutical policies: effects of regulating drug insurance schemes.Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2. Cochrane Database Syst Rev. 2022. PMID: 35502614 Free PMC article. Review.
-
Continuing versus New Antidepressant Use in Older Adults: US Prescribing Trends from 2006 to 2015.Eur Geriatr Med. 2018;9(4):551-555. doi: 10.1007/s41999-018-0075-x. Epub 2018 Jun 14. Eur Geriatr Med. 2018. PMID: 30524610 Free PMC article.
-
Trends in Serious Psychological Distress and Outpatient Mental Health Care of US Adults.JAMA Psychiatry. 2019 Feb 1;76(2):152-161. doi: 10.1001/jamapsychiatry.2018.3550. JAMA Psychiatry. 2019. PMID: 30484838 Free PMC article.
References
-
- Charney DS, Reynolds CF, Lewis L, et al. Depression and bipolar support alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life. Arch Gen Psych. 2003;60 - PubMed
-
- Bruce ML, Ten Have TR, Reynolds CF, 3rd, et al. Reducing suicidal ideation and depressive symptoms in depressed older primary care patients. JAMA. 2004;291:1081–1091. - PubMed
-
- Waern M, Rubenowitz E, Wilhelmson K. Predictors of suicide in the old elderly. Gerontology. 2003;49:328–334. - PubMed
-
- Katon W. Clinical and health services relationships between major depression, depressive symptoms, and general medical illness. Biological Psychiatry. 2003;54:216–226. - PubMed
-
- Unutzer J, Patrick DL, Simon GE, et al. Depressive symptoms and the cost of health services in HMO patients aged 65 years and older: a 4 year prospective study. JAMA. 1997;277:1618–1623. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AG027017/AG/NIA NIH HHS/United States
- K07 AG033174-01A1/AG/NIA NIH HHS/United States
- P30 AG024827-06/AG/NIA NIH HHS/United States
- R34 MH082682/MH/NIMH NIH HHS/United States
- P30 MH071944/MH/NIMH NIH HHS/United States
- R01 HS017695/HS/AHRQ HHS/United States
- K07AG033174/AG/NIA NIH HHS/United States
- R01AG027017/AG/NIA NIH HHS/United States
- T32 AG021885-01/AG/NIA NIH HHS/United States
- R01 AG034056/AG/NIA NIH HHS/United States
- K07 AG033174/AG/NIA NIH HHS/United States
- P30 AG024827/AG/NIA NIH HHS/United States
- R01HS017695/HS/AHRQ HHS/United States
- R34 MH082682-01A1/MH/NIMH NIH HHS/United States
- KL2 RR024154/RR/NCRR NIH HHS/United States
- P30AG024827/AG/NIA NIH HHS/United States
- R01 AG034056-02/AG/NIA NIH HHS/United States
- R01AG034056/AG/NIA NIH HHS/United States
- P30MH71944/MH/NIMH NIH HHS/United States
- T32AG021885/AG/NIA NIH HHS/United States
- KL2 TR000146/TR/NCATS NIH HHS/United States
- T32 AG021885/AG/NIA NIH HHS/United States
- KL2 RR-024154-04/RR/NCRR NIH HHS/United States
- KL2 RR024154-04/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
